CISPLATIN INJECTION, MYLAN STD.
CISPLATIN INJECTION, MYLAN STD.
Discontinued
DIN Number
02396890
Drug Class
Human
Market Date
Jun 12, 2013
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02396890
AIG Number0113245002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XA01 CISPLATIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CISPLATINActive
Strength: 1 MG / ML
Monograph: CISPLATIN